CLENBUTEROL 100 tabs x 0.04mg Clenbuterol

CLENBUTEROL – 100 Tablets × 0.04 mg Clenbuterol

Understanding CLENBUTEROL and Its Pharmaceutical Identity

CLENBUTEROL is a product name associated with clenbuterol, a compound belonging to the beta-2 adrenergic agonist group. The stated product presentation contains 0.04 mg (40 micrograms) of clenbuterol per tablet, with a declared package quantity of 100 tablets.

Clenbuterol has a distinct pharmacological profile because it acts on beta-2 adrenergic receptors. These receptors are involved in several physiological processes, particularly the regulation of smooth muscle activity in the respiratory system.

Although clenbuterol is frequently discussed in fitness and bodybuilding communities, it is important to distinguish these discussions from approved medical applications. Its availability and regulatory status differ between countries, and it should not be considered an ordinary nutritional supplement.

The Active Ingredient: Clenbuterol Explained

Clenbuterol is a synthetic sympathomimetic compound that stimulates beta-2 adrenergic receptors. These receptors are found in different tissues, including the smooth muscles surrounding the airways.

Activation of these receptors can cause relaxation of airway smooth muscle. This pharmacological action explains why clenbuterol has historically been associated with respiratory research and certain veterinary applications.

Unlike anabolic-androgenic steroids, clenbuterol does not belong to the testosterone-derived steroid family. Its mechanism of action is based on adrenergic receptor stimulation rather than direct androgen receptor activity.

This distinction is important when understanding its chemical identity and biological effects.

Pharmacological Characteristics and Receptor Activity

The primary pharmacological characteristic of clenbuterol is its activity at beta-2 adrenergic receptors.

These receptors are part of the body's sympathetic nervous system signalling network. Their activation can influence airway muscle activity, heart rate, metabolic processes, and other physiological functions.

Although its beta-2 activity is an important feature, clenbuterol is not completely free from cardiovascular effects. At higher exposure levels, or in susceptible individuals, its effects can extend beyond the respiratory system.

Its pharmacological activity therefore requires careful consideration rather than assumptions based on its intended receptor selectivity.

Medical Background and Historical Applications

Clenbuterol has been associated with respiratory medicine because of its bronchodilating properties. In certain countries, it has been authorised for specific respiratory conditions under medical supervision.

However, its approval is not universal. For example, the United States FDA has never approved clenbuterol for human use. Some formulations are authorised for veterinary applications, which must not be confused with medicines intended for people.

DEA Diversion Control Division+1

Its medical history demonstrates why the regulatory status of a product must be checked in the country where it is intended to be used.

Product Presentation and Identification

The stated product details provide the basic identification infor